Morphotek, Inc.

Eisai to Acquire Morphotek

Eisai to Acquire Morphotek

March 22, 2007

Eisai’s Dramatic Leap towards Biologic Therapeutics Evidenced by the Acquisition

Selventa

Genstruct Appoints VP of Scientific Research

Genstruct Appoints VP of Scientific Research

March 26, 2007

CAMBRIDGE, Mass., March 26, 2007 /PRNewswire/ -- Genstruct Inc., a biotechnology company translating the complexity of human biology to develop new successful therapeutics, today announced the appointment of Christian Reich, M.D., Ph.D. to vice president of Scientific Research. In this position, Dr. Reich will lead Genstruct's internal biology research teams as well as efforts in translational medicine and clinical research in partnership with its large pharmaceutical partners, which include GSK and Pfizer.

Mascoma Corporation

Mascoma Secures $4.9MM Funding from U.S. Department of Energy

Mascoma Secures $4.9MM Funding from U.S. Department of Energy

March 28, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in cellulosic biomass-to-biofuels development and production, today announced it has secured $4.9 million in funding from the U.S. Department of Energy (DOE). The funding is specifically for the development of fermentative organisms that speed the conversion of cellulosic biomass into ethanol, making it commercially viable to produce. Mascoma will utilize the funds for a joint project with the Oak Ridge National Laboratory in Tennessee, the DOE’s largest science and energy laboratory.

Acceleron Pharma, Inc.

Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing

Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing

March 29, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 29, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of Robert Steininger as Senior Vice President, Manufacturing.

Mascoma Corporation

Mascoma Co-Founder Dr. Lee Lynd Named Recipient of Inaugural Lemelson-MIT Award for Sustainability

Mascoma Co-Founder Dr. Lee Lynd Named Recipient of Inaugural Lemelson-MIT Award for Sustainability

April 2, 2007

CAMBRIDGE, MA, APRIL 2, 2007 – Mascoma Co-Founder and Dartmouth Engineering Professor Dr. Lee Lynd was today named the recipient of the first-ever Lemelson-MIT Award for Sustainability, which recognizes inventors whose products and processes enhance economic opportunity and community well-being, while protecting and restoring the natural environment.

AVEO Pharmaceuticals, Inc.

AVEO Enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO’s Novel Anti-HGF Antibody

AVEO Enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO’s Novel Anti-HGF Antibody

April 4, 2007

Company to Participate in Development and Commercialization

TransMedics, Inc.

TransMedics, Inc., Closes $25.5 Million in Series D Funding

TransMedics, Inc., Closes $25.5 Million in Series D Funding

April 13, 2007

ANDOVER, Mass.--(BUSINESS WIRE)--TransMedics, Inc., an emerging medical technology company developing advanced solutions to address the unmet need for better, more effective organ transplants, announced today that it has closed a $25.5 million Series D private equity financing led by funds affiliated with and advised by Tudor Investments.

Morphotek, Inc.

Eisai Announces Completion of Acquisition of Morphotek

Eisai Announces Completion of Acquisition of Morphotek

April 17, 2007

Woodcliff Lake, NJ, April 17, 2007 - Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., today announces the completion of Eisai’s acquisition of Morphotek®, Inc. for US$325 million after excess net cash. The companies received notice that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 was terminated early by the Federal Trade Commission.

Interactive Supercomputing Corporation

Interactive Supercomputing a Red Herring 100 winner

Interactive Supercomputing a Red Herring 100 winner

May 2, 2007

Award recognizes the 100 'Most Promising' companies driving the future of technology

SAN FRANCISCO, May 2 /PRNewswire/ -- Red Herring today announced that Interactive Supercomputing Inc. (ISC) is a recipient of the Red Herring 100 Spring, an award given to the top 100 private technology companies based in North America.

e-Dialog, Inc.

e-Dialog Recognized as One of Massachusetts' Fastest Growing Private Companies

e-Dialog Recognized as One of Massachusetts' Fastest Growing Private Companies

April 16, 2007

Boston Business Journal Names E-mail Service Provider as Regional Pacesetter

LEXINGTON, Mass., April 16, 2007 – e-Dialog, provider of advanced e-mail marketing services, today announced that it ranked No. 22 on the Boston Business Journal's list of the region's fastest growing private companies. The company was among 60 businesses honored during an event held on April 13th at the Park Plaza Hotel in Boston.